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EVALUATION OF VARYING DOSES OF MAGNESIUM AS 
AN ADJUVANT TO ROPIVACAINE IN SUPRACLAVICULAR 
BRACHIAL PLEXUS BLOCK 
ABSTRACT:  
Introduction: 
 Peripheral nerve blockade is one of the components of comprehensive 
anaesthesia care because of its distinct advantages over central neuraxial 
blockade and general anaesthesia. Peripheral nerve blockade provides more 
effective analgesia with fewer side effects than opioid and other oral analgesics. 
Supraclavicular block once described as the “spinal of the arm” offers dense 
anaesthesia of the brachial plexus for surgical procedures at or distal to the 
elbow. 
Ropivacaine is a long acting local anaesthetic that is structurally related 
to bupivacaine. It was developed for reducing systemic toxicity and improving 
relative sensory to motor block profiles. 
Magnesium has been used in intravenous, intrathecal, epidural/caudal 
routes to improve analgesia. Its role in peripheral nerve blocks has only minimal 
literature and available literature has shown mixed results. Hence this study was 
designed to evaluate the efficacy of magnesium when added to ropivacaine in 
supraclavicular brachial plexus block. 
Aim: 
This study is aimed to assess when two different doses of Magnesium 
added as an adjuvant to Ropivacaine in Ultrasound guided supraclavicular 
brachial plexus block may enhance the duration of sensory and motor block, 
duration of analgesia and quality of block and side effects using various 
parameters and to find out the minimum dose needed to achieve the desired 
effects. 
The primary objectives is to assess the onset and duration of sensory and 
motor blockade and duration of postop analgesia. 
The secondary objectives is to assess the total rescue analgesics, Visual 
Analog Scale(VAS) Score and side effects. 
Materials and Methods: 
Ninety patients of both sexes (18–60 years) posted for elective upper limb 
ortho surgeries under USG guided supraclavicular brachial plexus block were 
divided into three equal groups (Groups A, Group B and Group C) in a 
randomized, double‑ blind fashion. In group A (n = 30), 20 ml 0.5% 
ropivacaine 
plus 1.5 ml normal saline and in group B (n = 30), 20 ml 0.5% ropivacaine plus 
100 mg MgSO4 (diluted in 1.5 ml NS) and in Group C (n = 30), 20 ml 0.5% 
ropivacaine plus 150 mg MgSO4 (diluted in 1.5 ml NS) were administered in 
supraclavicular block. Sensory and motor block onset times and block 
durations, time to first analgesic use, total rescue analgesic need, postoperative 
visual analog scale (VAS) and side effects were recorded for each patient. 
Results: 
 The demographic profile of all the patients was statistically insignificant 
between the three groups. Our study showed that 
1. On addition of magnesium to local anaesthetic, the onset of sensory and 
motor blockade was delayed significantly (P <0.001 for both sensory and 
motor), but there was no significant difference between the two groups 
with 100 mg and 150 mg magnesium. (P value - 0.252 for both sensory 
and motor) 
2. Addition of magnesium to ropivacaine significantly prolongs the duration 
of sensory and motor blockade (P <0.001 for both sensory and motor) but 
did not have significant difference between the doses of 100 and 150 mg. 
(P value - 0.185 for sensory and P value - 0.164 for motor) 
3. Time to request of first rescue analgesic increased significantly when 
magnesium is added (P <0.001), but addition of 150 mg magnesium 
compared to 100 mg magnesium didn’t have much difference (P value-
0.464). Thus the postoperative analgesia is definitely better when 
magnesium is added. 
4. The total number of rescue injections in first 24 hours was less when 
magnesium is added similar to the above findings and thus the 
postoperative opiod consumption was less in magnesium group but 
without significant difference between 100 and 150 mg of magnesium. 
5. Minor complications like nausea and vomiting were rarely encountered 
and which was easily managed. 
 Conclusion: 
 From this study it is concluded that on addition of both 100 mg and 150 
mg magnesium sulphate to 0.5% ropivacaine in supraclavicular brachial plexus 
block significantly prolongs the duration of sensory and motor blockade and 
significantly reduces the requirement of rescue analgesic in postoperative period 
but delays the onset time of sensory and motor blockade. 
 But both 100 mg and 150 mg magnesium had similar efficacy of 
postoperative analgesia. Thus it is inferred that 100 mg magnesium is enough in 
supraclavicular block to achieve the desired effects.  
 
 
